A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
Washington Health Center strives to provide the highest quality care for people in Maryland, Virginia, and Washington, D.C., with compassion and respect. We know that our ability to treat others well begins with how we treat each other. Our 30,000 associates and 5,400 affiliated physicians are committed to living our core SPIRIT values—Service, Patient first, Integrity, Respect, Innovation, and Teamwork—no matter where they work across our diverse health system.
Washington, District of Columbia Clinical Trial Location
Washington Hospital Center – Oncology and Hematology
110 Irving St NW C2149,
Washington, DC 20010